Catálogo de publicaciones - libros
Título de Acceso Abierto
Immunotherapy, Tumor Microenvironment and Survival Signaling
Resumen/Descripción – provisto por la editorial
No disponible.
Palabras clave – provistas por la editorial
Autophagy; colorectal cancer; immunotherapy; tumor stroma; tumor microenvironment; immune checkpoint inhibitors; chemotherapy; tyrosine kinase inhibitors; angiogenesis; check point inhibitors; programmed cell death protein 1; programmed cell death 1 ligand 1; cardiotoxicity; lung metastasis; CAR-T; hypoxia; tumor; microenvironment; CD19; BCMA; cancer; melanoma; immune escape; antigen loss; chimeric antigen receptor; electroporation; lentivirus; lentiviral transduction; macrophages; leukemia cells; lytic peptides; targeted therapy; dendritic cells; pathogenesis; risk factors; breast cancer; resistance; checkpoint; targeted treatment; personalized medicine; pediatric solid tumors; chimeric antigen receptors; cancer vaccines; oncolytic viral therapy; immunomodulation; DCLK1; tumor stem cells; clonogenicity; mitochondria; mitochondrial transfer; tunneling nanotubes; triple-negative breast cancer; immune checkpoint inhibitor; combination therapy; cancer nanomedicine; tumor antigens; cancer metabolism; cancer immunotherapy; nanoparticles; immunotherapeutic agent; immunomodulators; tuft cells; cancer stem cells; immunotherapies; myeloid-derived suppressor cells; regulatory T cells; crosstalk; tumor immune evasion; cell–cell contact; β2 integrins; CD18; CD11; CAR-T cells; CD37; cell therapy; tumor antigen; lymphoma; CAR macrophage; CAR T cell; solid tumors; immunometabolism; miRNA; immunogenic cell death; n/a
Disponibilidad
Institución detectada | Año de publicación | Navegá | Descargá | Solicitá |
---|---|---|---|---|
No requiere | Directory of Open access Books |
Información
Tipo de recurso:
libros
ISBN electrónico
978-3-0365-4420-5
País de edición
Suiza